DECHRA PHARMACEUTICALS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,866 GBX | -.--% |
|
-.--% | +0.21% |
ETFs positioned on Dechra Pharmaceuticals
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 8.11% | 1 M€ | -.--% | ||
| 0.08% | 773 M€ | -.--% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.02% | 1,120 M€ | +0.38% | ||
| 0.02% | 0 M€ | 0.00% | - | |
| 0.02% | 31 M€ | +3.19% | - | |
| 0.00% | 34 M€ | +2.33% | - | |
| 0.00% | 389 M€ | +6.30% | - | |
| 0.00% | 17 M€ | +1.23% | - | |
| 0.00% | 34 M€ | +5.86% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 302 M€ | +3.92% | - | |
| 0.00% | 39 M€ | +3.47% | - | |
| 0.00% | 8 M€ | -0.53% | - | |
| 0.00% | 1 M€ | -.--% | - | |
| 0.00% | 29 M€ | -2.71% | - | |
| 0.00% | 152 M€ | -3.40% | - | |
| 0.00% | 26 M€ | 0.00% | - |
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows:
- companion animal products (74.6%);
- food producing animal products (11.5%);
- equine health products (7.3%);
- animal feeds (5.1%);
- other (1.5%): products manufactured by third parties.
Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Sector
-
- Stock Market
- Equities
- DPH Stock
- Funds and ETFs Dechra Pharmaceuticals
